Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Bosch, A. Lennertz, B. Schmidt, E. Fink, C. Keller, M. Toepfer, J. Dräger, W. Samtleben (2000)
DALI apheresis in hyperlipidemic patients: biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood.Artificial organs, 24 2
(2008)
Heart-UK LDL apheresis working group
T. Bosch, B. Schmidt, W. Kleophas, V. Otto, W. Samtleben (2008)
LDL hemoperfusion--a new procedure for LDL apheresis: biocompatibility results from a first pilot study in hypercholesterolemic atherosclerosis patients.Artificial organs, 21 10
G. Thompson (2008)
Recommendations for the use of LDL apheresis.Atherosclerosis, 198 2
T. Bosch, S. Gahr, Ulrike Belschner, C. Schaefer, A. Lennertz, J. Rammo (2006)
Direct Adsorption of Low‐Density Lipoprotein by DALI‐LDL‐Apheresis: Results of a Prospective Long‐term Multicenter Follow‐up Covering 12 291 SessionsTherapeutic Apheresis and Dialysis, 10
T. Bosch, B. Schmidt, M. Blumenstein, Gurland Hj (2008)
Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood.Artificial organs, 17 7
T. Bosch, A. Lennertz, D. Schenzle, J. Dräger (2002)
Direct adsorption of low‐density lipoprotein and lipoprotein(a) from whole blood: Results of the first clinical long‐term multicenter study using DALI apheresisJournal of Clinical Apheresis, 17
Dräger, Július, Kraenzle, Schaper, Toepfer, Zygan, Otto, Steinhagen‐Thiessen (1998)
DALI—the first human whole‐blood low‐density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical resultsEuropean Journal of Clinical Investigation, 28
Pancytopenia with severe thrombocytopenia occurred in a patient treated with low‐density lipoprotein (LDL)‐apheresis by polyacrylate adsorption from whole blood, after treatment frequency had been increased from once to twice a week. Cell counts recovered with discontinuation of LDL‐apheresis, but thrombocytopenia recurred after resumption of twice‐weekly treatments. Thrombocyte counts remained stable following the replacement of polyacrylate adsorption from whole blood by double‐filtration plasmapheresis. The complications' close coincidence with twice‐weekly polyacrylate adsorption from whole blood suggests a causal relationship, although by a still unknown mechanism. Monitoring of thrombocytes should be advised in patients treated with LDL‐apheresis by polyacrylate adsorption from whole blood. J. Clin. Apheresis 2010. © 2010 Wiley‐Liss, Inc.
Journal of Clinical Apheresis – Wiley
Published: Jan 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.